Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor SAR442168
Condition: Secondary Progressive Multiple Sclerosis Interventions: Drug: SAR442168; Drug: Placebo to match SAR442168 Sponsor: Sanofi Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials